These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 9088576)
21. Informed consent for a clinical trial in Thailand. Achrekar A; Gupta R N Engl J Med; 1998 Oct; 339(18):1331-2. PubMed ID: 9841301 [No Abstract] [Full Text] [Related]
22. Risk, Helsinki 2000 and the use of placebo in medical research. Saunders J; Wainwright P Clin Med (Lond); 2003; 3(5):435-9. PubMed ID: 14601942 [TBL] [Abstract][Full Text] [Related]
23. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Carpenter WT; Appelbaum PS; Levine RJ Am J Psychiatry; 2003 Feb; 160(2):356-62. PubMed ID: 12562584 [TBL] [Abstract][Full Text] [Related]
24. Is the placebo control obsolete in a world after donepezil and vitamin E? Karlawish JH; Whitehouse PJ Arch Neurol; 1998 Nov; 55(11):1420-4. PubMed ID: 9823825 [TBL] [Abstract][Full Text] [Related]
25. The ethics of placebo-controlled trials--a middle ground. Emanuel EJ; Miller FG N Engl J Med; 2001 Sep; 345(12):915-9. PubMed ID: 11565527 [No Abstract] [Full Text] [Related]
26. Placebo-controlled trials of new drugs: ethical considerations. Orentlicher D Diabetes Care; 2001 Apr; 24(4):771-2. PubMed ID: 11315846 [No Abstract] [Full Text] [Related]
27. Powerful placebo: the dark side of the randomised controlled trial. Kaptchuk TJ Lancet; 1998 Jun; 351(9117):1722-5. PubMed ID: 9734904 [No Abstract] [Full Text] [Related]
29. Module four: standards of care and clinical trials. Selgelid MJ Dev World Bioeth; 2005 Mar; 5(1):55-72. PubMed ID: 15748178 [TBL] [Abstract][Full Text] [Related]
30. Ethics of using controls and placebo in clinical trials. Wilde H; Phaosavasdi S; Pruksapong C; Tannirandorn Y; Taneepanichskul S J Med Assoc Thai; 1999 Jun; 82(6):632-5. PubMed ID: 10443090 [No Abstract] [Full Text] [Related]
31. Ethics and placebo-controlled thrombolytic trials: the future. Freedman B Coron Artery Dis; 1991 Sep; 2(7):849-52. PubMed ID: 11659532 [No Abstract] [Full Text] [Related]
32. Placebos and the UK Medical Research Council--and the consumer perspective. Box JE Sci Eng Ethics; 2004 Jan; 10(1):95-101. PubMed ID: 14986776 [TBL] [Abstract][Full Text] [Related]
34. More on the use of placebo controls. IRB; 2001; 23(6):11. PubMed ID: 12737177 [No Abstract] [Full Text] [Related]
35. The use of placebos in clinical trials for acute schizophrenia. Addington D Can J Psychiatry; 1995 May; 40(4):171-6. PubMed ID: 7621385 [TBL] [Abstract][Full Text] [Related]
37. The ethics of placebo-controlled trials. Weijer C J Bone Miner Res; 2003 Jun; 18(6):1150-3. PubMed ID: 12817774 [No Abstract] [Full Text] [Related]
38. Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspective. Rosenblatt M J Bone Miner Res; 2003 Jun; 18(6):1142-5. PubMed ID: 12817772 [TBL] [Abstract][Full Text] [Related]
39. Placebo controls in clinical trials of new therapies for osteoporosis. Levine RJ J Bone Miner Res; 2003 Jun; 18(6):1154-9. PubMed ID: 12817775 [No Abstract] [Full Text] [Related]
40. Placebo-controlled trials in type 2 diabetes. Misbin RI Diabetes Care; 2001 Apr; 24(4):773-4. PubMed ID: 11315847 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]